Literature DB >> 2882774

The mechanism of the antihypertensive effects of ketanserin: a comparison with metoprolol.

E Casiglia, R Gava, A Semplicini, P Nicolin, A C Pessina.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2882774      PMCID: PMC1401200          DOI: 10.1111/j.1365-2125.1986.tb02972.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Mechanism of antihypertensive action of ketanserin in man.

Authors:  I W Reimann; J C Frölich
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

2.  Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

Authors:  M L Cohen; R W Fuller; K S Wiley
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

3.  Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468).

Authors:  J M Van Nueten; P A Janssen; A De Ridder; P M Vanhoutte
Journal:  Eur J Pharmacol       Date:  1982-02-05       Impact factor: 4.432

4.  The effect of ketanserin in essential hypertension.

Authors:  A Anderson; T Morgan; R Dumpys
Journal:  Clin Exp Pharmacol Physiol       Date:  1983 May-Jun       Impact factor: 2.557

5.  Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension.

Authors:  L A Ferrara; M L Fasano; S Soro; P Rubba; A Iannuzzi
Journal:  J Clin Pharmacol       Date:  1985-04       Impact factor: 3.126

  5 in total
  2 in total

1.  Ketanserin in the treatment of diabetes-associated hypertension.

Authors:  C Beretta-Piccoli
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Comparative haemodynamic effects of ketanserin and ritanserin in the proximal and distal upper limb circulations of hypertensive patients.

Authors:  N P Chau; I Pithois-Merli; J Levenson; A C Simon
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.